ES515063A0 - "procedimiento para la preparacion de un derivado de 1,4-dehidropirimidina". - Google Patents

"procedimiento para la preparacion de un derivado de 1,4-dehidropirimidina".

Info

Publication number
ES515063A0
ES515063A0 ES515063A ES515063A ES515063A0 ES 515063 A0 ES515063 A0 ES 515063A0 ES 515063 A ES515063 A ES 515063A ES 515063 A ES515063 A ES 515063A ES 515063 A0 ES515063 A0 ES 515063A0
Authority
ES
Spain
Prior art keywords
dehydropyrimidine
derivative
procedure
preparation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES515063A
Other languages
English (en)
Other versions
ES8306364A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Lek Pharmaceuticals dd
Original Assignee
Lek Pharmaceuticals and Chemical Co dd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lek Pharmaceuticals and Chemical Co dd filed Critical Lek Pharmaceuticals and Chemical Co dd
Publication of ES515063A0 publication Critical patent/ES515063A0/es
Publication of ES8306364A1 publication Critical patent/ES8306364A1/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
    • C07D211/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Vascular Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Hydrogenated Pyridines (AREA)
ES515063A 1981-08-19 1982-08-17 "procedimiento para la preparacion de un derivado de 1,4-dehidropirimidina". Expired ES8306364A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
YU2005/81A YU41983B (en) 1981-08-19 1981-08-19 Process for preparing 1,4-dihydro-pyridine derivatives

Publications (2)

Publication Number Publication Date
ES515063A0 true ES515063A0 (es) 1983-06-01
ES8306364A1 ES8306364A1 (es) 1983-06-01

Family

ID=25556467

Family Applications (1)

Application Number Title Priority Date Filing Date
ES515063A Expired ES8306364A1 (es) 1981-08-19 1982-08-17 "procedimiento para la preparacion de un derivado de 1,4-dehidropirimidina".

Country Status (13)

Country Link
US (1) US4467093A (es)
JP (1) JPS5839663A (es)
AT (1) AT380876B (es)
CA (1) CA1185243A (es)
CH (1) CH651297A5 (es)
DK (1) DK155734C (es)
ES (1) ES8306364A1 (es)
FI (1) FI74275C (es)
NL (1) NL8203260A (es)
PL (1) PL131222B1 (es)
SE (1) SE441743B (es)
SU (1) SU1099842A3 (es)
YU (1) YU41983B (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4771057A (en) * 1986-02-03 1988-09-13 University Of Alberta Reduced pyridyl derivatives with cardiovascular regulating properties
JPH02118009U (es) * 1989-03-09 1990-09-21

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1670827C3 (de) * 1967-03-20 1974-10-24 Bayer Ag, 5090 Leverkusen 4-(2'-Nitrophenyl)-2,6-dimethyl-3,5-dicarbmethoxy-1,4-dihydropyridin
DE2808930A1 (de) * 1978-03-02 1979-09-06 Bayer Ag Verfahren zur herstellung von 2-nitrobenzaldehyd
JPS554318A (en) * 1978-06-23 1980-01-12 Asahi Chem Ind Co Ltd Preparation of 1,4-dihydropyridine
JPS5520719A (en) * 1978-07-31 1980-02-14 Asahi Chem Ind Co Ltd Preparation of 1,4-dihydropyridine derivative
JPS55124760A (en) * 1979-03-16 1980-09-26 Kanebo Ltd Preparation of 1,4-dihydropyridine derivative or its salt

Also Published As

Publication number Publication date
CA1185243A (en) 1985-04-09
DK155734C (da) 1989-09-25
FI822842A0 (fi) 1982-08-16
SU1099842A3 (ru) 1984-06-23
PL237935A1 (en) 1983-02-28
FI74275C (fi) 1988-01-11
PL131222B1 (en) 1984-10-31
SE441743B (sv) 1985-11-04
SE8204658D0 (sv) 1982-08-11
SE8204658L (sv) 1983-02-20
JPS5839663A (ja) 1983-03-08
DK155734B (da) 1989-05-08
CH651297A5 (de) 1985-09-13
ATA307082A (de) 1985-12-15
US4467093A (en) 1984-08-21
YU200581A (en) 1984-02-29
ES8306364A1 (es) 1983-06-01
NL8203260A (nl) 1983-03-16
FI74275B (fi) 1987-09-30
YU41983B (en) 1988-04-30
JPS6314709B2 (es) 1988-04-01
AT380876B (de) 1986-07-25
FI822842L (fi) 1983-02-20
DK370382A (da) 1983-02-20

Similar Documents

Publication Publication Date Title
ES510449A0 (es) Un procedimiento para la preparacion de 1,2,4-triazolonas.fenoxial-quilicas.
ES538256A0 (es) Un procedimiento para la preparacion de derivados de 2,2'-iminobisetanol.
ES512279A0 (es) Un procedimiento para la preparacion de 1,2-diamino clobuten-3,4-dionas.
ES514868A0 (es) "un procedimiento para la preparacion de un derivado de tiazol".
ES509449A0 (es) "un procedimiento de preparacion de derivados de 1,3-dihidro-6-metil-7-hidroxi-furo-3,4-c-piridina".
ES542703A0 (es) Un procedimiento para la preparacion de derivados de tiazol,2, 4, disustituidos.
ES515295A0 (es) "un procedimiento para la preparacion de imidazoquinazolinas".
ES510354A0 (es) Un procedimiento para la preparacion de 2,3-dicloro-5-triclorometilpiridina.
ES514992A0 (es) Un procedimiento para la preparacion de un derivado carbostirilo.
ES501432A0 (es) Un procedimiento para la preparacion de 4,5-diaril-&-cpolifluoralquil)-1-4-pirrol-2metanaminas antiinflamatorias.
ES501077A0 (es) Un procedimiento para la preparacion de 4-alquil-sustituido-3--hidroxi-3-pirrolin-2,5 dionas.
ES518291A0 (es) Un procedimiento para la preparacion de un derivado de piridoindol.
ES515305A0 (es) "un procedimiento para la preparacion de o-alquil s,s-dialquil fosforoditioatos".
ES510908A0 (es) "un procedimiento para la preparacion de derivados de piridinona".
ES528225A0 (es) Un procedimiento para la preparacion de nuevos derivados de 1,2,5,-tidiazol.
ES514572A0 (es) "un procedimiento para la preparacion de glutation".
ES510286A0 (es) "un procedimiento para la preparacion de nuevas fluoro-prostaciclinas".
ES510181A0 (es) "un procedimiento para la preparacion de 1-(1,3-bendodioxol-5-il)-2-pirrolidinona".
ES514571A0 (es) "un procedimiento para la preparacion de glutation".
ES510928A0 (es) "un procedimiento para la preparacion de mercapto-acil-carnitinas".
ES513832A0 (es) "un procedimiento para la preparacion de fenetilpiperidinas".
ES498635A0 (es) Un procedimiento para la preparacio,n de nuevos derivados de denzopirano 2,3-d-v-triazol.
ES520624A0 (es) Un procedimiento para la preparacion de derivados de 3-cxa-1-azabiciclo (4,2,0) octano.
ES515063A0 (es) "procedimiento para la preparacion de un derivado de 1,4-dehidropirimidina".
ES512463A0 (es) Un procedimiento para la preparacion de un derivado de beta-lactama.

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 19970203